Questions are swirling about the upcoming Inflation Reduction Act (IRA) drug changes — and for good reason. In just a few months, covered entities will have to navigate the challenges of handling the first 10 drugs reimbursed at the Maximum Fair Price (MFP). Both entities and pharmacies will be required to adapt quickly to this new reality — with significant implications for 340B savings, compliance, and access. In this session, we’ll break down: • How to calculate the potential impact on your 340B Program savings • The difference between IRA and Contract Pharmacy access restrictions • Updates from CMS & HRSA on compliance guidance • Key actions you can take now to prepare Why this matters: This is a critical topic with major financial and operational implications — and many details are still evolving. Staying informed and proactive is essential to avoid disruption and maximize your program outcomes.

Join us for a live webinar hosted by the Apexus Advanced 340B Operations Certificate Program. In this webinar, Reimagining 340B: How AI Is Shaping the Future of Program Compliance and Operations, we will be exploring how artificial intelligence is transforming 340B Program compliance and operations. As AI continues to evolve, it’s becoming a powerful tool for improving oversight, streamlining workflows, and supporting smarter decision-making within 340B programs — but it’s critical that these innovations are weighed with thoughtful attention to compliance.